Provided by Tiger Trade Technology Pte. Ltd.

OPKO Health

1.49
+0.00500.34%
Volume:1.40M
Turnover:2.08M
Market Cap:1.11B
PE:-15.88
High:1.51
Open:1.49
Low:1.47
Close:1.48
52wk High:1.73
52wk Low:0.9769
Shares:746.33M
Float Shares:324.00M
Volume Ratio:0.57
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0935
EPS(LYR):-0.3005
ROE:-5.88%
ROA:-5.52%
PB:0.94
PE(LYR):-4.94

Loading ...

OPKO Health Inc - Receives 15% Equity Stake in Nicoya

THOMSON REUTERS
·
Apr 30

Press Release: OPKO Health Expands Nicoya Agreement to Support RAYALDEE(R) Commercialization in Greater China

Dow Jones
·
Apr 30

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

GlobeNewswire
·
Apr 30

OPKO Health Down Over 13%, On Pace for Largest Percent Decrease Since January 2024 -- Data Talk

Dow Jones
·
Apr 30

Barrington Downgrades OPKO Health to Market Perform From Outperform

MT Newswires Live
·
Apr 29

OPKO Health Cut to Market Perform From Outperform by Barrington Research

Dow Jones
·
Apr 29

Opko Health downgraded to Market Perform from Outperform at Barrington

TIPRANKS
·
Apr 29

Earnings Flash (OPK) OPKO Health Posts Q1 Loss of $0.07 per Share, vs. FactSet Est of $0.07 Loss

MT Newswires Live
·
Apr 29

OPKO Health Q1 EPS $(0.07), Inline, Sales $124.200M Miss $130.514M Estimate

Benzinga Earnings
·
Apr 29

BRIEF-OPKO Health Q1 Net Income USD -54.8 Million

Reuters
·
Apr 29

Corrected-OPKO Health Q1 Revenue From Services USD 72.2 (Corrects Amount)

THOMSON REUTERS
·
Apr 29

OPKO Health Outlook Q2 2026 Total Revenue Between $127 Mln - $132 Mln

THOMSON REUTERS
·
Apr 29

OPKO Health Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
Apr 25

Opko’s ModeX begins Phase 1 trial of MDX2003 for relapsed B-cell lymphoma

Reuters
·
Apr 22

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

GlobeNewswire
·
Apr 22

BUZZ-OPKO Health rises as ModeX starts early trial of COVID-19 prevention antibody

Reuters
·
Apr 08

Opko’s ModeX doses first patients in Phase 1 MDX2301 COVID-19 prevention trial

Reuters
·
Apr 08

OPKO Health’s Modex Therapeutics Initiates Clinical Trial of Mdx2301 for the Prevention of Covid-19

THOMSON REUTERS
·
Apr 08

Opko Health director John A. Paganelli acquires USD 11,350 of common shares

Reuters
·
Mar 21

Opko Health appoints Subbarao V. Uppaluri as director

Reuters
·
Mar 20